BioInsights - Are you finishing strong in cell therapy manufacturing? Tackling your final fill and finish challenges with automation

Are you finishing strong in cell therapy manufacturing? Tackling your final fill and finish challenges with automation

Cell & Gene Therapy Insights 2021; 7(9), 1163–1171

10.18609/cgti.2021.158

Published: 11 November 2021
Innovator Insight
Dalip Sethi, Annie Cunningham

Fill and finish is a critical, high-value step in cell therapy manufacturing; failure is both costly for the manufacturer and potentially catastrophic for the patient waiting to receive therapy. This key step is frequently done manually, which poses a number of significant risks. In contrast, the Finia® Fill and Finish System, designed to automate this process, may reduce contamination and labor costs while improving reproducibility and supporting GMP compliance.